These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 4451791)

  • 1. Proceedings: High-affinity hepatic microsomal binding of propranolol: its relationship to metabolism and to the first-pass effect.
    McEwen J; Shand DG; Wilkinson GR; Stevenson IH
    Br J Pharmacol; 1974 Sep; 52(1):140P-140P. PubMed ID: 4451791
    [No Abstract]   [Full Text] [Related]  

  • 2. The inhibition of rat hepatic microsomal propranolol metabolism by a covalently bound reactive metabolite.
    Pritchard JF; Schneck DW; Hayes AH
    Res Commun Chem Pathol Pharmacol; 1980 Feb; 27(2):211-22. PubMed ID: 6768117
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The inhibitory effect of propranolol pretreatment on its own metabolism in the rat.
    Schneck DW; Pritchard JF
    J Pharmacol Exp Ther; 1981 Sep; 218(3):575-81. PubMed ID: 6267246
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nonspecific binding to microsomes: impact on scale-up of in vitro intrinsic clearance to hepatic clearance as assessed through examination of warfarin, imipramine, and propranolol.
    Obach RS
    Drug Metab Dispos; 1997 Dec; 25(12):1359-69. PubMed ID: 9394025
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Covalent binding of a reactive metabolite derived from propranolol and its active metabolite 4-hydroxypropranolol to hepatic microsomal proteins of the rat.
    Narimatsu S; Arai T; Watanabe T; Masubuchi Y; Horie T; Suzuki T; Ishikawa T; Tsutsui M; Kumagai Y; Cho AK
    Chem Res Toxicol; 1997 Mar; 10(3):289-95. PubMed ID: 9084908
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impaired elimination of propranolol due to right heart failure: drug clearance in the isolated liver and its relationship to intrinsic metabolic capacity.
    Ng CY; Ghabrial H; Morgan DJ; Ching MS; Smallwood RA; Angus PW
    Drug Metab Dispos; 2000 Oct; 28(10):1217-21. PubMed ID: 10997943
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatic microsomal propranolol metabolism in aging male and female rats.
    Fujita S; Ishida R; Obara S; Kitani K; Suzuki T
    J Pharm Sci; 1991 Feb; 80(2):199-200. PubMed ID: 2051331
    [No Abstract]   [Full Text] [Related]  

  • 8. Ion-trapping, microsomal binding, and unbound drug distribution in the hepatic retention of basic drugs.
    Siebert GA; Hung DY; Chang P; Roberts MS
    J Pharmacol Exp Ther; 2004 Jan; 308(1):228-35. PubMed ID: 14566005
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of hepatic metabolism affecting pharmacokinetics of propranolol in humans.
    Kiriyama A; Honbo A; Iga K
    Int J Pharm; 2008 Feb; 349(1-2):53-60. PubMed ID: 17765415
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regioselective contribution of the cytochrome P-450 2D subfamily to propranolol metabolism in rat liver microsomes.
    Masubuchi Y; Kagimoto N; Narimatsu S; Fujita S; Suzuki T
    Drug Metab Dispos; 1993; 21(6):1012-6. PubMed ID: 7905378
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The pathways of propranolol metabolism in dog and rat liver 10,000g supernatant fractions.
    Vu VT; Abramson FP
    Drug Metab Dispos; 1980; 8(5):300-4. PubMed ID: 6107225
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of hypothermia on drug metabolism. In vitro studies with propranolol and verapamil.
    McAllister RG; Tan TG
    Pharmacology; 1980; 20(2):95-100. PubMed ID: 7384193
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo study of propranolol and metabolite(s) disposition in rat liver.
    Ong H; du Souich P; Marchand C
    Drug Metab Dispos; 1981; 9(6):529-34. PubMed ID: 6120811
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolic kinetics of pseudoracemic propranolol in human liver microsomes. Enantioselectivity and quinidine inhibition.
    Marathe PH; Shen DD; Nelson WL
    Drug Metab Dispos; 1994; 22(2):237-47. PubMed ID: 8013280
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Species differences for stereoselective hydrolysis of propranolol prodrugs in plasma and liver.
    Yoshigae Y; Imai T; Horita A; Otagiri M
    Chirality; 1997; 9(7):661-6. PubMed ID: 9366026
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of vitamin K3 on the first-pass elimination of propranolol in the rat.
    Ishida R; Usui T; Fukushima Y; Fujita S; Suzuki T
    J Pharm Sci; 1985 May; 74(5):578-81. PubMed ID: 4020639
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regio- and stereoselective propranolol metabolism by 15 forms of purified cytochromes P-450 from rat liver.
    Fujita S; Umeda S; Funae Y; Imaoka S; Abe H; Ishida R; Adachi T; Masuda M; Kazusaka A; Suzuki T
    J Pharmacol Exp Ther; 1993 Jan; 264(1):226-33. PubMed ID: 8423527
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rat liver microsomal metabolism of propranolol: identification of seven metabolites by gas chromatography-mass spectrometry.
    Tindell GL; Walle T; Gaffney TE
    Life Sci II; 1972 Nov; 11(21):1029-36. PubMed ID: 4659696
    [No Abstract]   [Full Text] [Related]  

  • 19. Fentanyl metabolism by human hepatic and intestinal cytochrome P450 3A4: implications for interindividual variability in disposition, efficacy, and drug interactions.
    Labroo RB; Paine MF; Thummel KE; Kharasch ED
    Drug Metab Dispos; 1997 Sep; 25(9):1072-80. PubMed ID: 9311623
    [TBL] [Abstract][Full Text] [Related]  

  • 20. N-Dealkylation of propranolol: trapping of the 3-(1-naphthoxy)-2-hydroxypropionaldehyde formed in rat liver microsomes.
    Chen CH; Nelson WL
    Drug Metab Dispos; 1982; 10(3):277-8. PubMed ID: 6125363
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.